Additional Resources
Top Commentators:
- Elliott Abrams
- Fouad Ajami
- Shlomo Avineri
- Benny Avni
- Alan Dershowitz
- Jackson Diehl
- Dore Gold
- Daniel Gordis
- Tom Gross
- Jonathan Halevy
- David Ignatius
- Pinchas Inbari
- Jeff Jacoby
- Efraim Karsh
- Mordechai Kedar
- Charles Krauthammer
- Emily Landau
- David Makovsky
- Aaron David Miller
- Benny Morris
- Jacques Neriah
- Marty Peretz
- Melanie Phillips
- Daniel Pipes
- Harold Rhode
- Gary Rosenblatt
- Jennifer Rubin
- David Schenkar
- Shimon Shapira
- Jonathan Spyer
- Gerald Steinberg
- Bret Stephens
- Amir Taheri
- Josh Teitelbaum
- Khaled Abu Toameh
- Jonathan Tobin
- Michael Totten
- Michael Young
- Mort Zuckerman
Think Tanks:
- American Enterprise Institute
- Brookings Institution
- Center for Security Policy
- Council on Foreign Relations
- Heritage Foundation
- Hudson Institute
- Institute for Contemporary Affairs
- Institute for Counter-Terrorism
- Institute for Global Jewish Affairs
- Institute for National Security Studies
- Institute for Science and Intl. Security
- Intelligence and Terrorism Information Center
- Investigative Project
- Jerusalem Center for Public Affairs
- RAND Corporation
- Saban Center for Middle East Policy
- Shalem Center
- Washington Institute for Near East Policy
Media:
- CAMERA
- Daily Alert
- Jewish Political Studies Review
- MEMRI
- NGO Monitor
- Palestinian Media Watch
- The Israel Project
- YouTube
Government:
Back
(The Hill) David Adesnik and Saeed Ghasseminejad - U.S. media have widely reported that U.S. sanctions are responsible for dangerous pharmaceutical shortages in Iran, even though humanitarian goods, including food and medicine, are clearly exempt under U.S. law. The evidence tells a different story, however. EU data show that pharmaceutical exports from the EU to Iran actually rose slightly during the first half of 2019 compared to the same period last year, after the U.S. reinstated most sanctions in November 2018. Chinese customs data likewise show that Iranian pharmaceutical imports increased. The question to ask is why Iran does not spend more on such imports if consumers are complaining about shortages, instead of bankrolling Hizbullah, Hamas, and Bashar al-Assad. President Hassan Rouhani's first health minister, Ghazizadeh Hashemi, commented, "The problems that we have in the field of pharmaceutical products have been created by ourselves inside the country and the medicine problem has nothing to do with the sanctions." This is not the first time that superficial press coverage has lent credibility to Iranian talking points about the negative impact of sanctions. Iranian leaders understand that Americans have sincere humanitarian concerns that Tehran can manipulate. David Adesnik is director of research at the Foundation for Defense of Democracies, where Saeed Ghasseminejad is a senior Iran and financial economics advisor. 2019-12-04 00:00:00Full Article
Media Coverage Is Wrong about Medical Impact of Sanctions in Iran
(The Hill) David Adesnik and Saeed Ghasseminejad - U.S. media have widely reported that U.S. sanctions are responsible for dangerous pharmaceutical shortages in Iran, even though humanitarian goods, including food and medicine, are clearly exempt under U.S. law. The evidence tells a different story, however. EU data show that pharmaceutical exports from the EU to Iran actually rose slightly during the first half of 2019 compared to the same period last year, after the U.S. reinstated most sanctions in November 2018. Chinese customs data likewise show that Iranian pharmaceutical imports increased. The question to ask is why Iran does not spend more on such imports if consumers are complaining about shortages, instead of bankrolling Hizbullah, Hamas, and Bashar al-Assad. President Hassan Rouhani's first health minister, Ghazizadeh Hashemi, commented, "The problems that we have in the field of pharmaceutical products have been created by ourselves inside the country and the medicine problem has nothing to do with the sanctions." This is not the first time that superficial press coverage has lent credibility to Iranian talking points about the negative impact of sanctions. Iranian leaders understand that Americans have sincere humanitarian concerns that Tehran can manipulate. David Adesnik is director of research at the Foundation for Defense of Democracies, where Saeed Ghasseminejad is a senior Iran and financial economics advisor. 2019-12-04 00:00:00Full Article
Search Daily Alert
Search:
|